Meng Lu

1.9k total citations
36 papers, 988 citations indexed

About

Meng Lu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Meng Lu has authored 36 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Immunology and 9 papers in Oncology. Recurrent topics in Meng Lu's work include Pluripotent Stem Cells Research (5 papers), Immune cells in cancer (5 papers) and Mycobacterium research and diagnosis (4 papers). Meng Lu is often cited by papers focused on Pluripotent Stem Cells Research (5 papers), Immune cells in cancer (5 papers) and Mycobacterium research and diagnosis (4 papers). Meng Lu collaborates with scholars based in China, United States and India. Meng Lu's co-authors include SF Chen, Meng Xiang, Shyamal Goswami, Fangming Zhu, Dandan Zhang, Xiaoming Zhang, Jiaqiang Ma, Haiquan Chen, Qin Chen and Qiang Gao and has published in prestigious journals such as Nucleic Acids Research, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Meng Lu

33 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng Lu China 16 481 325 322 165 117 36 988
Gang Cai China 15 404 0.8× 270 0.8× 394 1.2× 244 1.5× 125 1.1× 34 1.0k
Arezoo Gowhari Shabgah Iran 21 405 0.8× 385 1.2× 547 1.7× 152 0.9× 130 1.1× 44 1.3k
Junfeng Wang China 16 413 0.9× 184 0.6× 296 0.9× 215 1.3× 73 0.6× 37 867
Xiaojun Zhu China 20 303 0.6× 227 0.7× 261 0.8× 184 1.1× 118 1.0× 70 905
Chao Su China 18 571 1.2× 206 0.6× 193 0.6× 224 1.4× 144 1.2× 44 976
Aiqun Liu China 17 392 0.8× 257 0.8× 204 0.6× 159 1.0× 65 0.6× 59 874
Yaping Wu China 17 251 0.5× 337 1.0× 195 0.6× 88 0.5× 83 0.7× 30 820
Yan Du China 19 649 1.3× 321 1.0× 317 1.0× 256 1.6× 194 1.7× 53 1.4k

Countries citing papers authored by Meng Lu

Since Specialization
Citations

This map shows the geographic impact of Meng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Lu more than expected).

Fields of papers citing papers by Meng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Lu. The network helps show where Meng Lu may publish in the future.

Co-authorship network of co-authors of Meng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Lu. A scholar is included among the top collaborators of Meng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Lu. Meng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Feixiang, Yubiao Guo, Yue Luo, et al.. (2025). Myeloid‐Driven Immune Suppression Subverts Neutralizing Antibodies and T Cell Immunity in Severe COVID‐19. Journal of Medical Virology. 97(4). e70335–e70335. 1 indexed citations
3.
Feng, Xinyu, Yingfang Guo, Aftab Shaukat, et al.. (2025). Bta-miR-93 regulates the maternal-fetal tolerance in dairy cows via promoting Programmed Cell Death Ligand 1 mediated M2 macrophage polarization. Biology of Reproduction. 112(5). 880–894. 1 indexed citations
4.
Lu, Meng, Yumin Zhang, Ya-Wei Guo, et al.. (2024). Platelets promote primary hepatocellular carcinoma metastasis through TGF-β1-mediated cancer cell autophagy. Cancer Letters. 600. 217161–217161. 12 indexed citations
5.
Qian, Meirui, Xue Liang, Jing Lin, et al.. (2024). Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway. Cell Communication and Signaling. 22(1). 583–583.
6.
Li, Jiaxin, Mao Zhang, Siyuan Huang, et al.. (2024). Multi-model analysis of gallbladder cancer reveals the role of OxLDL-absorbing neutrophils in promoting liver invasion. Experimental Hematology and Oncology. 13(1). 58–58. 6 indexed citations
8.
Li, Xingyu, Meng Lu, Qianqian Ding, et al.. (2023). iPSC-derived exosomes promote angiogenesis in naturally aged mice. Aging. 15(12). 5854–5872. 12 indexed citations
9.
10.
Lv, Jianjun, Hao Wang, Hong‐Yong Cui, et al.. (2021). Blockade of Macrophage CD147 Protects Against Foam Cell Formation in Atherosclerosis. Frontiers in Cell and Developmental Biology. 8. 609090–609090. 9 indexed citations
11.
Liu, Ze-Kun, Can Li, Renyu Zhang, et al.. (2021). EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling. Molecular Cancer. 20(1). 79–79. 40 indexed citations
12.
Wang, Xiaokai, Meng Lu, Xiao Yu Tian, et al.. (2020). Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey. Stem Cell Research & Therapy. 11(1). 334–334. 12 indexed citations
13.
Du, Yu, Qian Wang, Na Tian, et al.. (2020). Knockdown of nrf2 Exacerbates TNF‐ α ‐Induced Proliferation and Invasion of Rheumatoid Arthritis Fibroblast‐Like Synoviocytes through Activating JNK Pathway. Journal of Immunology Research. 2020(1). 6670464–6670464. 30 indexed citations
14.
Sun, Ruiting, Yingying Liu, Meng Lu, et al.. (2019). ALIX increases protein content and protective function of iPSC-derived exosomes. Journal of Molecular Medicine. 97(6). 829–844. 28 indexed citations
15.
Zhang, Shuhao, Shyamal Goswami, Jiaqiang Ma, et al.. (2019). CD4+T Cell Subset Profiling in Biliary Atresia Reveals ICOS− Regulatory T Cells as a Favorable Prognostic Factor. Frontiers in Pediatrics. 7. 279–279. 13 indexed citations
16.
Xiang, Meng, Meng Lu, Jing Quan, et al.. (2018). Direct in vivo application of induced pluripotent stem cells is feasible and can be safe. Theranostics. 9(1). 290–310. 21 indexed citations
17.
Zhang, Jingwei, Yuan Sun, Yaoyao Wang, et al.. (2014). Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor. European Journal of Pharmacology. 740. 277–284. 36 indexed citations
18.
Lu, Meng, Jiao Wu, Feng He, et al.. (2014). Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma. Journal of Molecular Histology. 46(1). 79–91. 7 indexed citations
19.
Zhang, Jingwei, Fang Zhou, Xiaolan Wu, et al.. (2011). Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)‐ginsenoside Rh2 in MCF‐7/Adr cells. British Journal of Pharmacology. 165(1). 120–134. 81 indexed citations
20.
Wang, Rui, Jie Zhang, Sufeng Chen, et al.. (2011). Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression. Lung Cancer. 74(2). 188–196. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026